{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T12:10:54Z","timestamp":1781179854321,"version":"3.54.1"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T00:00:00Z","timestamp":1720569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["PHRC 2009 20-17"],"award-info":[{"award-number":["PHRC 2009 20-17"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","thebreastonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Breast"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.breast.2024.103776","type":"journal-article","created":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T06:36:19Z","timestamp":1722666979000},"page":"103776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1994-8590","authenticated-orcid":false,"given":"A.","family":"Dezellus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Mirallie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Leperlier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9160-7307","authenticated-orcid":false,"given":"B.","family":"Sauterey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.-E.","family":"Bouet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Dessaint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Duros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.S.","family":"Gremeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.-A.","family":"Mouret-Reynier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.M.","family":"Durand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Venat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"De Blay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6711-2942","authenticated-orcid":false,"given":"M.","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Freour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Campone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Blanc-Lapierre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Bordes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.breast.2024.103776_bib1","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/sj.bjc.6603783","article-title":"Recent increase of breast cancer incidence among women under the age of forty","volume":"96","author":"Bouchardy","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.breast.2024.103776_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s12253-010-9305-3","article-title":"Breast cancer under 40 years of age: increasing number and worse prognosis","volume":"17","author":"Dobi","year":"2011","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.breast.2024.103776_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10549-016-3983-9","article-title":"Long-term outcome in young women with breast cancer: a population-based study","volume":"160","author":"Fredholm","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103776_bib4","doi-asserted-by":"crossref","first-page":"3500","DOI":"10.1002\/cncr.31638","article-title":"Trends in breast cancer mortality by stage at diagnosis among young women in the United States","volume":"124","author":"Guo","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.breast.2024.103776_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.ejca.2017.03.035","article-title":"Prospective evaluation of serum anti-M\u00fcllerian hormone dynamics in 250 women of reproductive age treated with chemotherapy for breast cancer","volume":"79","author":"Dezellus","year":"2017","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.breast.2024.103776_bib6","series-title":"ESHRE guideline: female fertility preservation. Hum Reprod Open 2020:hoaa052","article-title":"ESHRE guideline group on female fertility preservation","year":"2020"},{"key":"10.1016\/j.breast.2024.103776_bib7","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa1413204","article-title":"Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy","volume":"372","author":"Moore","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2024.103776_bib8","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib9","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib10","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic Group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib11","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1200\/JCO.2018.78.1914","article-title":"Fertility preservation in patients with cancer: ASCO clinical practice guideline update","volume":"36","author":"Oktay","year":"2018","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib12","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.annonc.2020.09.006","article-title":"Fertility preservation and post-treatment pregnancies in post-pubertal cancer patients: ESMO Clinical Practice Guidelines","volume":"31","author":"Lambertini","year":"2020","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib13","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1210\/jc.2015-3878","article-title":"Long-term safety of letrozole and gonadotropin stimulation for fertility preservation in women with breast cancer","volume":"101","author":"Kim","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.breast.2024.103776_bib14","first-page":"568","article-title":"Response to ovarian stimulation is not impacted by a breast cancer diagnosis","volume":"32","author":"Quinn","year":"2017","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.breast.2024.103776_bib15","first-page":"2051","article-title":"Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response","volume":"33","author":"Alvarez","year":"2018","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.breast.2024.103776_bib16","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.fertnstert.2014.05.017","article-title":"Tamoxifen co-administration during controlled ovarian hyperstimulation for in vitro fertilization in breast cancer patients increases the safety of fertility-preservation treatment strategies","volume":"102","author":"Meirow","year":"2014","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2024.103776_bib17","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.fertnstert.2008.10.007","article-title":"Ovarian stimulation for fertility preservation in patients with cancer","volume":"93","author":"Quintero","year":"2010","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2024.103776_bib18","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1093\/humrep\/deac145","article-title":"Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols","volume":"37","author":"Balkenende","year":"2022","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.breast.2024.103776_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s10815-020-02030-y","article-title":"Effects of letrozole or tamoxifen coadministered with a standard stimulation protocol on fertility preservation among breast cancer patients","volume":"38","author":"Shulman","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.breast.2024.103776_bib20","doi-asserted-by":"crossref","first-page":"4347","DOI":"10.1200\/JCO.2005.05.037","article-title":"Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation","volume":"23","author":"Oktay","year":"2005","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.574669","article-title":"Efficacy and safety of controlled ovarian stimulation with or without letrozole Co-administration for fertility preservation: a systematic review and meta-analysis","volume":"10","author":"Bonardi","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/humrep\/deac035","article-title":"Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysis","volume":"37","author":"Arecco","year":"2022","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.breast.2024.103776_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2023.05.030","article-title":"Fertility preservation, its effectiveness and its impact on disease status in pre-menopausal women with breast cancer: a systematic review and meta-analysis","volume":"287","author":"White","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.breast.2024.103776_bib24","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.fertnstert.2013.03.029","article-title":"Ovarian stimulation in cancer patients","volume":"99","author":"Cakmak","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2024.103776_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ejogrb.2016.02.006","article-title":"Timing of ovarian stimulation in patients prior to gonadotoxic therapy: an analysis of 684 stimulations","volume":"199","author":"von Wolff","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.breast.2024.103776_bib26","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1007\/s10815-021-02273-3","article-title":"Concomitant tamoxifen or letrozole for optimal oocyte yield during fertility preservation for breast cancer: the TAmoxifen or Letrozole in Estrogen Sensitive tumors (TALES) randomized clinical trial","volume":"38","author":"Letourneau","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.breast.2024.103776_bib27","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/humrep\/des445","article-title":"A prospective case series of women with estrogen receptor-positive breast cancer: levels of tamoxifen metabolites in controlled ovarian stimulation with high-dose tamoxifen","volume":"28","author":"Balkenende","year":"2013","journal-title":"Hum Reprod Oxf Engl"},{"key":"10.1016\/j.breast.2024.103776_bib28","first-page":"CD002249","article-title":"Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome","volume":"12","author":"Brown","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.breast.2024.103776_bib29","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/carcin\/22.6.839","article-title":"Understanding the genotoxicity of tamoxifen?","volume":"22","author":"Phillips","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.breast.2024.103776_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10549-017-4288-3","article-title":"Fertility preservation with ovarian stimulation and time to treatment in women with stage II-III breast cancer receiving neoadjuvant therapy","volume":"165","author":"Chien","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103776_bib31","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1200\/JCO.2013.49.7693","article-title":"Clinical impact of delaying initiation of adjuvant chemotherapy in patients with breast cancer","volume":"32","author":"Gagliato","year":"2014","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1634\/theoncologist.2019-0744","article-title":"Impact of delayed neoadjuvant systemic chemotherapy on overall survival among patients with breast cancer","volume":"25","author":"de Melo Gagliato","year":"2020","journal-title":"Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s10549-017-4555-3","article-title":"Safety of fertility preservation in breast cancer patients in a register-based matched cohort study","volume":"167","author":"Rodriguez-Wallberg","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103776_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10549-020-06031-4","article-title":"Predictors and outcomes in breast cancer patients who did or did not pursue fertility preservation","volume":"186","author":"Moravek","year":"2021","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.breast.2024.103776_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.breast.2021.12.006","article-title":"The impact of young age at diagnosis (age <40 years) on prognosis varies by breast cancer subtype: a U.S. SEER database analysis","volume":"61","author":"Kim","year":"2022","journal-title":"Breast Edinb Scotl"},{"key":"10.1016\/j.breast.2024.103776_bib36","article-title":"Effect of age on breast cancer patient prognoses: a population-based study using the SEER 18 database","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.breast.2024.103776_bib37","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib38","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa2212856","article-title":"Interrupting endocrine therapy to attempt pregnancy after breast cancer","volume":"388","author":"Partridge","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.breast.2024.103776_bib39","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1200\/JCO.23.02292","article-title":"Fertility preservation and assisted reproduction in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy","volume":"42","author":"Azim","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib40","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1200\/JCO.2014.59.3723","article-title":"Fertility preservation success subsequent to concurrent aromatase inhibitor treatment and ovarian stimulation in women with breast cancer","volume":"33","author":"Oktay","year":"2015","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib41","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/jamaoncol.2022.3677","article-title":"Relapse rates and disease-specific mortality following procedures for fertility preservation at time of breast cancer diagnosis","volume":"8","author":"Marklund","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.breast.2024.103776_bib42","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.rbmo.2015.12.008","article-title":"Anti-M\u00fcllerian hormone in breast cancer patients treated with chemotherapy: a retrospective evaluation of subsequent pregnancies","volume":"32","author":"Hamy","year":"2016","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.breast.2024.103776_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.fertnstert.2022.10.014","article-title":"Markers of ovarian reserve as predictors of future fertility","volume":"119","author":"Harris","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/j.breast.2024.103776_bib44","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.2023.25463","article-title":"Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study","volume":"331","author":"Lambertini","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.breast.2024.103776_bib45","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.3390\/cancers15204923","article-title":"The role of cyclin-dependent kinases (CDK) 4\/6 in the ovarian tissue and the possible effects of their exogenous inhibition","volume":"15","author":"Scavone","year":"2023","journal-title":"Cancers"}],"container-title":["The Breast"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960977624001073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,12]],"date-time":"2024-09-12T01:32:50Z","timestamp":1726104770000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960977624001073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":45,"alternative-id":["S0960977624001073"],"URL":"https:\/\/doi.org\/10.1016\/j.breast.2024.103776","relation":{},"ISSN":["0960-9776"],"issn-type":[{"value":"0960-9776","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of tamoxifene-controlled ovarian hyperstimulation for fertility preservation before breast cancer treatment: A prospective cohort study with a 5-year follow-up","name":"articletitle","label":"Article Title"},{"value":"The Breast","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.breast.2024.103776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103776"}}